DisGeNET is a knowledge management platform that integrates and standardizes the data of genes and mutations related to diseases from multiple sources. It covers entire range of human disease.
Source | Last Updated |
---|---|
DisGeNET | July 29, 2024 |
Disease ID | Disease Name | Gene Symbol | Gene ID | Gene Name | UniProt ID ▲ |
---|---|---|---|---|---|
C0006826 | Malignant Neoplasms | ALG2 | 85365 | ALG2 alpha-1,3/1,6-mannosyltransferase | Q9H553 |
C1842836 | CONGENITAL DISORDER OF GLYCOSYLATION, TYPE Ii | ALG2 | 85365 | ALG2 alpha-1,3/1,6-mannosyltransferase | Q9H553 |
C0751885 | Myasthenic Syndromes, Congenital, Slow Channel | ALG2 | 85365 | ALG2 alpha-1,3/1,6-mannosyltransferase | Q9H553 |
C0086543 | Cataract | ALG2 | 85365 | ALG2 alpha-1,3/1,6-mannosyltransferase | Q9H553 |
C0006142 | Malignant neoplasm of breast | ALG2 | 85365 | ALG2 alpha-1,3/1,6-mannosyltransferase | Q9H553 |
C0015469 | Facial paralysis | ALG2 | 85365 | ALG2 alpha-1,3/1,6-mannosyltransferase | Q9H553 |
C0520947 | Clumsiness - motor delay | ALG2 | 85365 | ALG2 alpha-1,3/1,6-mannosyltransferase | Q9H553 |
C0016202 | Flatfoot | ALG2 | 85365 | ALG2 alpha-1,3/1,6-mannosyltransferase | Q9H553 |
C0005745 | Blepharoptosis | ALG2 | 85365 | ALG2 alpha-1,3/1,6-mannosyltransferase | Q9H553 |
C0751884 | Congenital Myasthenic Syndromes, Presynaptic | ALG2 | 85365 | ALG2 alpha-1,3/1,6-mannosyltransferase | Q9H553 |
C0678222 | Breast Carcinoma | ALG2 | 85365 | ALG2 alpha-1,3/1,6-mannosyltransferase | Q9H553 |
C0028738 | Nystagmus | ALG2 | 85365 | ALG2 alpha-1,3/1,6-mannosyltransferase | Q9H553 |
C1621958 | Glioblastoma Multiforme | ALG2 | 85365 | ALG2 alpha-1,3/1,6-mannosyltransferase | Q9H553 |
C0278878 | Adult Glioblastoma | ALG2 | 85365 | ALG2 alpha-1,3/1,6-mannosyltransferase | Q9H553 |
C3714756 | Intellectual Disability | ALG2 | 85365 | ALG2 alpha-1,3/1,6-mannosyltransferase | Q9H553 |
C0036439 | Scoliosis, unspecified | ALG2 | 85365 | ALG2 alpha-1,3/1,6-mannosyltransferase | Q9H553 |
C0036572 | Seizures | ALG2 | 85365 | ALG2 alpha-1,3/1,6-mannosyltransferase | Q9H553 |
C0017636 | Glioblastoma | ALG2 | 85365 | ALG2 alpha-1,3/1,6-mannosyltransferase | Q9H553 |
C1847540 | Azoospermia, Nonobstructive | ELOVL6 | 79071 | ELOVL fatty acid elongase 6 | Q9H5J4 |
C0033860 | Psoriasis | ELOVL6 | 79071 | ELOVL fatty acid elongase 6 | Q9H5J4 |
C0027651 | Neoplasms | ELOVL6 | 79071 | ELOVL fatty acid elongase 6 | Q9H5J4 |
C0011860 | Diabetes Mellitus, Non-Insulin-Dependent | ELOVL6 | 79071 | ELOVL fatty acid elongase 6 | Q9H5J4 |
C1800706 | Idiopathic Pulmonary Fibrosis | ELOVL6 | 79071 | ELOVL fatty acid elongase 6 | Q9H5J4 |
C1704272 | Benign Prostatic Hyperplasia | ELOVL6 | 79071 | ELOVL fatty acid elongase 6 | Q9H5J4 |
C2239176 | Liver carcinoma | ELOVL6 | 79071 | ELOVL fatty acid elongase 6 | Q9H5J4 |
GlyCosmos is a member of the GlySpace Alliance together with GlyGen and Glycomics@ExPASy.
Supported by JST NBDC Grant Number JPMJND2204
Partly supported by NIH Common Fund Grant #1U01GM125267-01
GlyCosmos Portal v4.0.0
Last updated: August 19, 2024